X4 PHARMACEUTICALS, INC (XFOR) Operating income 2016–2025
X4 PHARMACEUTICALS, INC (XFOR) annual operating income history from SEC filings — each fiscal year as reported.
-$86.9MFY2025 · since FY2016: -$24.3M → -$86.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$86.9M | -138.7% |
| FY2024 | -$36.4M | +66.1% |
| FY2023 | -$107.5M | -22.8% |
| FY2022 | -$87.6M | -2.9% |
| FY2021 | -$85.1M | -42.1% |
| FY2020 | -$59.9M | -15.8% |
| FY2019 | -$51.7M | -77.8% |
| FY2018 | -$29.1M | -30.7% |
| FY2017 | -$22.2M | +8.6% |
| FY2016 | -$24.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More XFOR financial trends
XFOR RevenueXFOR Net incomeXFOR Net marginXFOR Gross profitXFOR Gross marginXFOR Operating marginXFOR Operating cash flowXFOR Free cash flowXFOR Capital expendituresXFOR Return on equityXFOR Stock buybacksXFOR Dividends paidXFOR Total assetsXFOR Total liabilitiesXFOR Shareholders’ equityXFOR overview →